Pretreatment clinical variables associated with the response to intravitreal bevacizumab (Avastin) injection in patients with persistent diabetic macular edema | Zendy

Fareed A. Warid AL-Laftah | Zendy; Maha Elshafie | Zendy; Mustafa Al-Hashimi | Zendy; Aant Pai | Zendy; Mohammad Farouq | Zendy

Open Access

Pretreatment clinical variables associated with the response to intravitreal bevacizumab (Avastin) injection in patients with persistent diabetic macular edema

Author(s) -

Fareed A. Warid AL-Laftah,

Maha Elshafie,

Mustafa Al-Hashimi,

Aant Pai,

Mohammad Farouq

Publication year - 2010

Publication title -

saudi journal of ophthalmology

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 0.359

H-Index - 25

eISSN - 2542-6680

pISSN - 1319-4534

DOI - 10.1016/j.sjopt.2010.05.001

Subject(s) - medicine , ophthalmology , diabetic retinopathy , visual acuity , macular edema , intraocular pressure , bevacizumab , triamcinolone acetonide , macular degeneration , diabetes mellitus , surgery , chemotherapy , endocrinology

The purpose of the study is to determine whether the pre-treatment clinical systemic variables and optical coherence tomography (OCT) findings are associated with the subsequent response to the intravitreal bevacizumab (IVB) in eyes with persistent diabetic macular edema (DME).

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research